ロード中...
A Microfluidic Platform for Single Cell Fluorometric Granzyme B Profiling
Granzyme B (GrB) is an essential cytotoxic effector in cancer immunotherapy as it can be a potential biomarker to predict the efficacy of immunotherapies including checkpoint inhibitors. Monitoring the Granzyme B activity in cells would help determine a patient's clinical response to treatment...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6929635/ https://ncbi.nlm.nih.gov/pubmed/31903110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.37728 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|